Robust tumor immunity to melanoma mediated by interleukin 9
Interleukin-9 is a T cell cytokine that acts through a γC-family receptor on target cells. We determined that T cells from mice deficient in the TH17 pathway genes ROR-γ and IL-23R produced abundant IL-9, and observed significant growth inhibition of B16F10 melanoma tumor in these mice. IL-9 blockin...
Main Authors: | Purwar, Rahul, Schlapbach, Christoph, Xiao, Sheng, Kang, Hong Soon, Elyaman, Wassim, Jiang, Xiaodong, Jetten, Anton M, Khoury, Samia J., Fuhlbrigge, Robert C, Kuchroo, Vijay K, Clark, Rachael A, Kupper, Thomas S |
---|---|
Format: | Online |
Language: | English |
Published: |
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518666/ |
Similar Items
-
Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis
by: Elyaman, Wassim, et al.
Published: (2011) -
Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity
by: Jiang, Xiaodong, et al.
Published: (2012) -
Notch Signaling and T-Helper Cells in EAE/MS
by: Bassil, Ribal, et al.
Published: (2013) -
Tiam1/Rac1 complex controls Il17a transcription and autoimmunity
by: Kurdi, Ahmed T., et al.
Published: (2016) -
Expression of interleukin 10 in human melanoma.
by: Krüger-Krasagakes, S., et al.
Published: (1994)